#ITI#Immunization of Turkeys with a DNA Vaccine Expressing Either the F or N Gene of Avian Metapneumovirus#FTI#
#IRE#In this study we compared protection by DNA vaccination with the F (pCMV-F) or N (pCMV-N) gene from avian metapneumovirus (aMPV) in turkeys. One-week-old turkey poults received two intramuscular injections 2 wk apart. Birds were challenged with a turkey-embryo-adapted aMPV at 5 wk of age. Birds vaccinated with pCMV-F had decreased clinical signs of disease as well as significantly reduced virus load in tracheal swabs compared with birds vaccinated with pCMV-N or unvaccinated control birds. Serum neutralizing antibodies were significantly higher in birds receiving pCMV-F compared with all other groups. These results indicate that DNA vaccination with the F, but not N, gene of aMPV can induce significant protection against aMPV infection.#FRE#
#IPC#Avian metapneumovirus; DNA vaccination; Protection#FPC#
#IRF#Alexander D.J., Newcastle disease and other Paramyxoviridae infections, Diseases of Poultry, 10th Ed., pp. 541-569, (1997); 
Alexander D.J., Gough R.E., Wyeth P.J., Lister S.A., Chettle N.J., Viruses associated with turkey rhinotracheitis in Great Britain, Vet. Rec., 118, pp. 217-218, (1986); 
Bangham C.R., Openshaw P.J., Ball L.A., King A.M., Wertz G.W., Askonas B.A., Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants, J. Immunol., 137, pp. 3973-3977, (1986); 
Barbeito M.S., Abraham G., Best M., Cairns P., Langevin P., Sterritt W.G., Barr D., Meulepas W., Sanchez-Vizcaino J.M., Saraza M., Requena E., Collado M., Mani P., Breeze R., Brunner H., Mebus C.A., Morgan R.L., Rusk S., Siegfried L.M., Thompson L.H., Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. First International Veterinary Biosafety Workshop, Rev. Sci. Tech., 14, pp. 873-887, (1995); 
Bembridge G.P., Rodriguez N., Garcia-Beato R., Nicolson C., Melero J.A., Taylor G., DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation, J. Gen. Virol., 81, pp. 2519-2523, (2000); 
Cook J.K., Huggins M.B., Woods M.A., Orbell S.J., Mockett A.P., Protection provided by a commercially available vaccine against different strains of turkey rhinotracheitis virus, Vet. Rec., 136, pp. 392-393, (1995); 
Cook J.K.A., Ellis M.M., Dolby C.A., Holmes H.C., Finney P.M., Huggins M.B., A live attenuated turkey rhinotracheitis virus vaccine. 2. The use of the attenuated strain as an experimental vaccine, Avian Pathol., 18, pp. 523-533, (1989); 
Cook J.K.A., Orthel F., Orbell S., Woods M.A., Huggins M.B., An experimental turkey rhinotracheitis (TRT) infection in breeding turkeys and the prevention of its clinical effects using live-attenuated and inactivated TRT vaccines, Avian Pathol., 25, pp. 231-243, (1996); 
Donnelly J.J., Ulmer J.B., Liu M.A., Immunization with DNA, J. Immunol. Methods, 176, pp. 145-152, (1994); 
Giraud P., Bennejean G., Guittet M., Toquin D., Turkey rhinotracheitis in France: Preliminary investigations on a ciliostatic virus, Vet. Rec., 119, pp. 606-607, (1986); 
Gough R.E., Alexander D.J., Wyeth P.J., Avian rhinotracheitis (pneumovirus), A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 4th Ed., pp. 164-168, (1998); 
Hafez H.M., Lohren U., Swollen head syndrome: Clinical observations and serological examinations in West Germany, Dtscli. Tieraerztl. Wochenschr., 97, pp. 322-324, (1990); 
Jirjis F.F., Noll S.L., Martin F., Halvorson D.A., Nagaraja K.V., Shaw D.P., Vaccination of turkeys with an avian pneumovirus isolate from the United States, Avian Dis., 45, pp. 1006-1013, (2001); 
Jones R.C., Avian pneumovirus infection: Questions still unanswered, Avian Pathol., 25, pp. 639-648, (1996); 
King A.M., Stott E.J., Langer S.J., Young K.K., Ball L.A., Wertz G.W., Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: Studies of gene expression in cell culture and immune response in mice, J. Virol., 61, pp. 2885-2890, (1987); 
Li X., Sambhara S., Li C.X., Ettorre L., Switzer I., Gates G., James O., Parrington M., Oomen R., Du R.P., Klein M., Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate, Virology, 269, pp. 54-65, (2000); 
McDougall J.S., Cook J.K., Turkey rhinotracheitis: Preliminary investigations, Vet. Rec., 118, pp. 206-207, (1986); 
Miller M., Cho J.Y., Back K.J., Castaneda D., Nayar J., Rodriguez M., Roman M., Raz E., Broide D.H., Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness, Vaccine, 20, pp. 3023-3033, (2002); 
Naylor C.J., Jones R.C., Demonstration of a virulent subpopulation in a prototype live attenuated turkey rhinotracheitis vaccine, Vaccine, 12, pp. 1225-1230, (1994); 
Oshop G.L., Elankumaran S., Meckert R.A., DNA vaccination in the avian, Vet. Immunol. Immunopathol., 89, pp. 1-12, (2002); 
Park E.K., Soh B.Y., Jang Y.S., Park J.H., Chung G.H., Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus, Mol. Cells, 12, pp. 50-56, (2001); 
Patnayak D.P., Sheikh A.M., Gulati B.R., Goyal S.M., Experimental and field evaluation of a live vaccine against avian pneumovirus, Avian Pathol., 31, pp. 377-382, (2002); 
Pemberton R.M., Cannon M.J., Openshaw P.J., Ball L.A., Wertz G.W., Askonas B.A., Cytotoxic T cell specificity for respiratory syncytial virus proteins: Fusion protein is an important target antigen, J. Gen. Virol., 68, pp. 2177-2182, (1987); 
Pringle C.R., Virus taxonomy 1996 - A bulletin from the Xth International Congress of Virology in Jerusalem, Arch. Virol., 141, pp. 2251-2256, (1996); 
Qingzhong Y., Barrett T., Brown T.D., Cook J.K., Green P., Skinner M.A., Cavanagh D., Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F), Vaccine, 12, pp. 569-573, (1994); 
Reed L.J., Muench H., A simple method for estimating fifty percent endpoints, Am. J. Hyg., 27, pp. 493-497, (1938); 
Robinson H.L., Hunt L.A., Webster R.G., Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA, Vaccine, 11, pp. 957-960, (1993); 
Sakaguchi M., Nakamura H., Sonoda K., Hamada F., Hirai K., Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus, Vaccine, 14, pp. 747-752, (1996); 
Schrijver R.S., Langedijk J.P., Keil G.M., Middel W.G., Maris-Veldhuis M., Van Oirschot J.T., Rijsewijk F.A., Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV, Vaccine, 15, pp. 1908-1916, (1997); 
Schrijver R.S., Langedijk J.P., Keil G.M., Middel W.G., Maris-Veldhuis M., Van Oirschot J.T., Rijsewijk F.A., Comparison of DNA application methods to reduce BRSV shedding in cattle, Vaccine, 16, pp. 130-134, (1998); 
Seal B.S., Matrix protein gene nucleotide and predicted amino acid sequence demonstrate that the first US avian pneumovirus isolate is distinct from European strains, Virus Res., 58, pp. 45-52, (1998); 
Shin H.J., McComb B., Back A., Shaw D.P., Halvorson D.A., Nagaraja K.V., Susceptibility of broiler chicks to infection by avian pneumovirus of turkey origin, Avian Dis., 44, pp. 797-802, (2000); 
Tripp R.A., Moore D., Jones L., Sullender W., Winter J., Anderson L.J., Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice, J. Virol., 73, pp. 7099-7107, (1999); 
Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Feigner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A., Heterologous protection against influenza by injection of DNA encoding a viral protein, Science, 259, pp. 1745-1749, (1993); 
Vanrompay D., Cox E., Kaiser P., Lawson S., Van Loock M., Volckaert G., Goddeeris B., Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization, Immunology, 103, pp. 106-112, (2001); 
Vanrompay D., Cox E., Volckaert G., Goddeeris B., Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein, Clin. Exp. Immunol., 118, pp. 49-55, (1999); 
Wyeth P.J., Gough R.E., Chettle N., Eddy R., Preliminary observations on a virus associated with turkey rhinotracheitis, Vet. Rec., 119, (1986)#FRF#
